Close Menu

NEW YORK (GenomeWeb) – Genome-editing biotech firm EdiGene announced yesterday that it has raised $10 million in a Series pre-B Plus financing round, which was led by new investor Green Pine Capital Partners.

Series A lead investor IDG Capital and Series B lead investor Lilly Asia Ventures also participated in the pre-B Plus financing, as well as other insiders, the firm noted.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.